| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-735 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
2022-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e466be6889829230e5702ea7f4682af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55d64e53c486e2dda39dc7ff671b882b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_908d2f59a96ea4c00f173c67caaee67f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31673dd2a6ae10c8938a3c4b45991273
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_518c6649053066d281436b7758b2e8e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77e8db3b62f2d3565a59f36d5792a1fa |
| publicationDate |
2022-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022192634-A1 |
| titleOfInvention |
Compositions and methods for dominant antiviral therapy |
| abstract |
In aspects, the invention provides novel compositions and methods for dominant inhibition of viral infection. |
| priorityDate |
2021-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |